Main Article Content
Objectives: To assess the accuracy of capillary whole blood glucose compared to conventional venous plasma glucose testing for 50-g GCT in GDM screening.
Materials and Methods: A total of 180 women at-risk for GDM were randomly selected and enrolled and a 50-g GCT was offered as a screening test. At 1 hour after glucose loading, a capillary glucose testing was performed by well-trained nurses using a Nova Biomedical StatStrip®. Within 5 minutes after capillary glucose test, venipuncture was then performed by certified technicians and venous blood was sent to a certified central laboratory to determine plasma glucose value. Results from POCT glucose testing were compared with venous plasma glucose (gold standard) to evaluate for its accuracy. Women with venous plasma glucose ≥ 140 mg/dL were offered 100-g OGTT for GDM diagnosis according to current guideline.
Results: Mean age was 33.1 years and 53.9% were nulliparous. Common GDM risks were age ≥ 30 years (87.8%), family history of DM (32.2%), and BMI ≥ 25 kg/m2 (25%). Mean gestational age at screening was 14.4 weeks. Mean venous plasma glucose was 131.6 ± 34.9 mg/dL and mean POCT glucose was 149.3 ± 27.7 mg/dL. Mean difference was 17.7 ± 19.4 mg/dL, corresponding to 16.8 ± 18.3%. POCT results were significantly correlated with venous plasma glucose (correlation coefficient 0.832, p < 0.001). GDM was diagnosed in 16 women (8.9%). At 140 mg/dL cut off, abnormal GCT was found in 37% by venous plasma glucose and 61% by POCT glucose results. Using 140 mg/dL cut off, POCT glucose has 97.1% sensitivity and 73.9% accuracy. At 165 mg/dL cut off, POCT glucose has 98.2% specificity and 82.8% accuracy.
Conclusion: POCT capillary glucose testing could be considered as an alternative to conventional venous glucose testing for 50-g GCT for GDM screening using 140 and 165 mg/dL cut off values.
Keywords: gestational diabetes, 50-g glucose challenge test, venous plasma glucose, capillary glucose, accuracy.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2017; 40 (Supplement 1): S11-24.
3. Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 2015; 131 Suppl 3: S173-211.
4. Buhling KJ, Henrich W, Kjos SL, Siebert G, Starr E, Dreweck C, et al. Comparison of point-of-care-testing glucose meters with standard laboratory measurement of the 50g-glucose-challenge test (GCT) during pregnancy. Clin Biochem 2003; 36: 333-7.
5. Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana RM, Deepa M, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol 2016; 53: 91-7.
6. Dhatt GS, Agarwal MM, Othman Y, Nair SC. Performance of the Roche Accu-Chek active glucose meter to screen for gestational diabetes mellitus using fasting capillary blood. Diabetes Technol Ther 2011; 13: 1229-33.
7. Carr SR, Slocum J, Tefft L, Haydon B, Carpenter M. Precision of office-based blood glucose meters in screening for gestational diabetes. Am J Obstet Gynecol 1995; 173: 1267-72.
8. Murphy NJ, Meyer BA, O'Kell RT, Hogard ME. Screening for gestational diabetes mellitus with a reflectance photometer: accuracy and precision of the single-operator model. Obstet Gynecol 1994; 83: 1038-42.
9. Teplick FB, Lindenbaum CR, Cohen AW. Cost-effective approach to office screening for gestational diabetes. J Perinatol 1990; 10: 301-3.
10. Daly N, Carroll C, Flynn I, Harley R, Maguire PJ, Turner MJ. Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus. BJOG 2017; 124: 1746-52.
11. Marley JV, Davis S, Coleman K, Hayhow BD, Brennan G, Mein JK, et al. Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia. Med J Aust 2007; 186: 500-3.
12. Balaji V, Balaji MS, Paneerselvam A, Thiyagarajah A, Seshiah V. Point of care for gestational diabetes mellitus--a community-based study. J Indian Med Assoc 2012; 110 :314-6.
13. Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison of venous plasma glucose and capillary whole blood glucose in the diagnosis of gestational diabetes mellitus: a community-based study. Diabetes Technol Ther 2012; 14: 131-4.
14. Srimaekarat T. Capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes. J Med Assoc Thai 2009; 92: 1268-72.
15. Sunsaneevithayakul P, Boriboohirunsarn D, Sutanthavibul A, Ruangvutilert P, Kanokpongsakdi S, Singkiratana D, et al. Risk factor-based selective screening program for gestational diabetes mellitus in Siriraj Hospital: result from clinical practice guideline. J Med Assoc Thai 2003; 86: 708-14.
16. Dacus JV, Schulz K, Sibai BM, Gonzalez-Ruiz A. Comparison of capillary and plasma glucose values in screening and oral glucose tolerance testing in pregnancy. J Reprod Med 1990; 35: 1150-2.
17. Yoo T, Chao J. Screening for gestational diabetes mellitus. Use and accuracy of capillary blood glucose measured with a reflectance meter. J Fam Pract 1989; 29: 41-4.